1 Docetaxel Injection Market Overview
1.1 Product Overview and Scope of Docetaxel Injection
1.2 Docetaxel Injection Segment by Type
1.2.1 Global Docetaxel Injection Market Value Comparison by Type (2023-2029)
1.2.2 10mg/ml
1.2.3 20mg/ml
1.2.4 40mg/ml
1.2.5 Others
1.3 Docetaxel Injection Segment by Application
1.3.1 Global Docetaxel Injection Market Value by Application: (2023-2029)
1.3.2 Adenocarcinoma
1.3.3 Non-small Cell Tumor
1.3.4 Lung Cancer
1.3.5 Ovarian Cancer
1.3.6 Pancreatic Cancer
1.3.7 Stomach Cancer
1.3.8 Head and Neck Cancer
1.3.9 Others
1.4 Global Docetaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Docetaxel Injection Revenue 2018-2029
1.4.2 Global Docetaxel Injection Sales 2018-2029
1.4.3 Global Docetaxel Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Docetaxel Injection Market Competition by Manufacturers
2.1 Global Docetaxel Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Docetaxel Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Docetaxel Injection Average Price by Manufacturers (2018-2023)
2.4 Global Docetaxel Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Docetaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Docetaxel Injection, Product Type & Application
2.7 Docetaxel Injection Market Competitive Situation and Trends
2.7.1 Docetaxel Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Docetaxel Injection Players Market Share by Revenue
2.7.3 Global Docetaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Docetaxel Injection Retrospective Market Scenario by Region
3.1 Global Docetaxel Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Docetaxel Injection Global Docetaxel Injection Sales by Region: 2018-2029
3.2.1 Global Docetaxel Injection Sales by Region: 2018-2023
3.2.2 Global Docetaxel Injection Sales by Region: 2024-2029
3.3 Global Docetaxel Injection Global Docetaxel Injection Revenue by Region: 2018-2029
3.3.1 Global Docetaxel Injection Revenue by Region: 2018-2023
3.3.2 Global Docetaxel Injection Revenue by Region: 2024-2029
3.4 North America Docetaxel Injection Market Facts & Figures by Country
3.4.1 North America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Docetaxel Injection Sales by Country (2018-2029)
3.4.3 North America Docetaxel Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Docetaxel Injection Market Facts & Figures by Country
3.5.1 Europe Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Docetaxel Injection Sales by Country (2018-2029)
3.5.3 Europe Docetaxel Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Docetaxel Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Docetaxel Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Docetaxel Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Docetaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Docetaxel Injection Sales by Country (2018-2029)
3.7.3 Latin America Docetaxel Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Docetaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Docetaxel Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Docetaxel Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Docetaxel Injection Sales by Type (2018-2029)
4.1.1 Global Docetaxel Injection Sales by Type (2018-2023)
4.1.2 Global Docetaxel Injection Sales by Type (2024-2029)
4.1.3 Global Docetaxel Injection Sales Market Share by Type (2018-2029)
4.2 Global Docetaxel Injection Revenue by Type (2018-2029)
4.2.1 Global Docetaxel Injection Revenue by Type (2018-2023)
4.2.2 Global Docetaxel Injection Revenue by Type (2024-2029)
4.2.3 Global Docetaxel Injection Revenue Market Share by Type (2018-2029)
4.3 Global Docetaxel Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Docetaxel Injection Sales by Application (2018-2029)
5.1.1 Global Docetaxel Injection Sales by Application (2018-2023)
5.1.2 Global Docetaxel Injection Sales by Application (2024-2029)
5.1.3 Global Docetaxel Injection Sales Market Share by Application (2018-2029)
5.2 Global Docetaxel Injection Revenue by Application (2018-2029)
5.2.1 Global Docetaxel Injection Revenue by Application (2018-2023)
5.2.2 Global Docetaxel Injection Revenue by Application (2024-2029)
5.2.3 Global Docetaxel Injection Revenue Market Share by Application (2018-2029)
5.3 Global Docetaxel Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Docetaxel Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Corporation Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Accord Healthcare Docetaxel Injection Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Alkem Labs
6.3.1 Alkem Labs Corporation Information
6.3.2 Alkem Labs Description and Business Overview
6.3.3 Alkem Labs Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Alkem Labs Docetaxel Injection Product Portfolio
6.3.5 Alkem Labs Recent Developments/Updates
6.4 AuroMedics Pharma
6.4.1 AuroMedics Pharma Corporation Information
6.4.2 AuroMedics Pharma Description and Business Overview
6.4.3 AuroMedics Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AuroMedics Pharma Docetaxel Injection Product Portfolio
6.4.5 AuroMedics Pharma Recent Developments/Updates
6.5 Dr. Reddy’s Laboratories
6.5.1 Dr. Reddy’s Laboratories Corporation Information
6.5.2 Dr. Reddy’s Laboratories Description and Business Overview
6.5.3 Dr. Reddy’s Laboratories Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dr. Reddy’s Laboratories Docetaxel Injection Product Portfolio
6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Fresenius Kabi Docetaxel Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Getwell Oncology
6.6.1 Getwell Oncology Corporation Information
6.6.2 Getwell Oncology Description and Business Overview
6.6.3 Getwell Oncology Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Getwell Oncology Docetaxel Injection Product Portfolio
6.7.5 Getwell Oncology Recent Developments/Updates
6.8 GLS Pharma
6.8.1 GLS Pharma Corporation Information
6.8.2 GLS Pharma Description and Business Overview
6.8.3 GLS Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GLS Pharma Docetaxel Injection Product Portfolio
6.8.5 GLS Pharma Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hikma Docetaxel Injection Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Hospira
6.10.1 Hospira Corporation Information
6.10.2 Hospira Description and Business Overview
6.10.3 Hospira Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hospira Docetaxel Injection Product Portfolio
6.10.5 Hospira Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Docetaxel Injection Description and Business Overview
6.11.3 Pfizer Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Docetaxel Injection Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Seacross Pharmaceuticals
6.12.1 Seacross Pharmaceuticals Corporation Information
6.12.2 Seacross Pharmaceuticals Docetaxel Injection Description and Business Overview
6.12.3 Seacross Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Seacross Pharmaceuticals Docetaxel Injection Product Portfolio
6.12.5 Seacross Pharmaceuticals Recent Developments/Updates
6.13 Teikoku Pharma USA
6.13.1 Teikoku Pharma USA Corporation Information
6.13.2 Teikoku Pharma USA Docetaxel Injection Description and Business Overview
6.13.3 Teikoku Pharma USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Teikoku Pharma USA Docetaxel Injection Product Portfolio
6.13.5 Teikoku Pharma USA Recent Developments/Updates
6.14 Teva Pharmaceuticals USA
6.14.1 Teva Pharmaceuticals USA Corporation Information
6.14.2 Teva Pharmaceuticals USA Docetaxel Injection Description and Business Overview
6.14.3 Teva Pharmaceuticals USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Teva Pharmaceuticals USA Docetaxel Injection Product Portfolio
6.14.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.15 Xiromed
6.15.1 Xiromed Corporation Information
6.15.2 Xiromed Docetaxel Injection Description and Business Overview
6.15.3 Xiromed Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xiromed Docetaxel Injection Product Portfolio
6.15.5 Xiromed Recent Developments/Updates
6.16 Aosaikang Pharmaceutical
6.16.1 Aosaikang Pharmaceutical Corporation Information
6.16.2 Aosaikang Pharmaceutical Docetaxel Injection Description and Business Overview
6.16.3 Aosaikang Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Aosaikang Pharmaceutical Docetaxel Injection Product Portfolio
6.16.5 Aosaikang Pharmaceutical Recent Developments/Updates
6.17 Beijing Union Pharmaceutical Factory
6.17.1 Beijing Union Pharmaceutical Factory Corporation Information
6.17.2 Beijing Union Pharmaceutical Factory Docetaxel Injection Description and Business Overview
6.17.3 Beijing Union Pharmaceutical Factory Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing Union Pharmaceutical Factory Docetaxel Injection Product Portfolio
6.17.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.18 Cisen Pharmaceutical
6.18.1 Cisen Pharmaceutical Corporation Information
6.18.2 Cisen Pharmaceutical Docetaxel Injection Description and Business Overview
6.18.3 Cisen Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Cisen Pharmaceutical Docetaxel Injection Product Portfolio
6.18.5 Cisen Pharmaceutical Recent Developments/Updates
6.19 Acebright Pharmaceuticals
6.19.1 Acebright Pharmaceuticals Corporation Information
6.19.2 Acebright Pharmaceuticals Docetaxel Injection Description and Business Overview
6.19.3 Acebright Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Acebright Pharmaceuticals Docetaxel Injection Product Portfolio
6.19.5 Acebright Pharmaceuticals Recent Developments/Updates
6.20 Hisun Pharmaceutical
6.20.1 Hisun Pharmaceutical Corporation Information
6.20.2 Hisun Pharmaceutical Docetaxel Injection Description and Business Overview
6.20.3 Hisun Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Hisun Pharmaceutical Docetaxel Injection Product Portfolio
6.20.5 Hisun Pharmaceutical Recent Developments/Updates
6.21 Hanhui Pharmaceutical
6.21.1 Hanhui Pharmaceutical Corporation Information
6.21.2 Hanhui Pharmaceutical Docetaxel Injection Description and Business Overview
6.21.3 Hanhui Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Hanhui Pharmaceutical Docetaxel Injection Product Portfolio
6.21.5 Hanhui Pharmaceutical Recent Developments/Updates
6.22 Hengrui Pharmaceuticals
6.22.1 Hengrui Pharmaceuticals Corporation Information
6.22.2 Hengrui Pharmaceuticals Docetaxel Injection Description and Business Overview
6.22.3 Hengrui Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Hengrui Pharmaceuticals Docetaxel Injection Product Portfolio
6.22.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.23 Meida Kangjiale
6.23.1 Meida Kangjiale Corporation Information
6.23.2 Meida Kangjiale Docetaxel Injection Description and Business Overview
6.23.3 Meida Kangjiale Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Meida Kangjiale Docetaxel Injection Product Portfolio
6.23.5 Meida Kangjiale Recent Developments/Updates
6.24 Qilu Pharmaceutical
6.24.1 Qilu Pharmaceutical Corporation Information
6.24.2 Qilu Pharmaceutical Docetaxel Injection Description and Business Overview
6.24.3 Qilu Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Qilu Pharmaceutical Docetaxel Injection Product Portfolio
6.24.5 Qilu Pharmaceutical Recent Developments/Updates
6.25 Taiji Pharmaceutical
6.25.1 Taiji Pharmaceutical Corporation Information
6.25.2 Taiji Pharmaceutical Docetaxel Injection Description and Business Overview
6.25.3 Taiji Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Taiji Pharmaceutical Docetaxel Injection Product Portfolio
6.25.5 Taiji Pharmaceutical Recent Developments/Updates
6.26 Wansheng Pharmaceutical
6.26.1 Wansheng Pharmaceutical Corporation Information
6.26.2 Wansheng Pharmaceutical Docetaxel Injection Description and Business Overview
6.26.3 Wansheng Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Wansheng Pharmaceutical Docetaxel Injection Product Portfolio
6.26.5 Wansheng Pharmaceutical Recent Developments/Updates
6.27 Main Luck Pharmaceuticals
6.27.1 Main Luck Pharmaceuticals Corporation Information
6.27.2 Main Luck Pharmaceuticals Docetaxel Injection Description and Business Overview
6.27.3 Main Luck Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Main Luck Pharmaceuticals Docetaxel Injection Product Portfolio
6.27.5 Main Luck Pharmaceuticals Recent Developments/Updates
6.28 Yangtze River Pharmaceutical
6.28.1 Yangtze River Pharmaceutical Corporation Information
6.28.2 Yangtze River Pharmaceutical Docetaxel Injection Description and Business Overview
6.28.3 Yangtze River Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Yangtze River Pharmaceutical Docetaxel Injection Product Portfolio
6.28.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.29 Chia Tal-tianqing Pharmaceutical
6.29.1 Chia Tal-tianqing Pharmaceutical Corporation Information
6.29.2 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Description and Business Overview
6.29.3 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Product Portfolio
6.29.5 Chia Tal-tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Docetaxel Injection Industry Chain Analysis
7.2 Docetaxel Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Docetaxel Injection Production Mode & Process
7.4 Docetaxel Injection Sales and Marketing
7.4.1 Docetaxel Injection Sales Channels
7.4.2 Docetaxel Injection Distributors
7.5 Docetaxel Injection Customers
8 Docetaxel Injection Market Dynamics
8.1 Docetaxel Injection Industry Trends
8.2 Docetaxel Injection Market Drivers
8.3 Docetaxel Injection Market Challenges
8.4 Docetaxel Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 ドセタキセル注射液は、癌治療に使用される抗がん剤であり、特に固形腫瘍に対する効果が期待される薬剤です。ドセタキセルは、タキサン系に属する薬剤であり、植物由来の化合物であるパクリタキセルと同じカテゴライズに入りますが、構造的には異なります。この薬剤は、細胞が分裂する過程を妨げることによって腫瘍細胞の増殖を抑制します。 ドセタキセルの基本的な働きは、微小管に結合することによって細胞分裂を阻害することです。具体的には、細胞分裂の際に必要な微小管の形成を干渉し、その結果、細胞周期が停止し、腫瘍細胞が増殖できなくなります。このメカニズムにより、ドセタキセルは進行したがんに対して効果を発揮します。 ドセタキセルの特徴としては、他の抗がん剤と比較して腫瘍に対する選択性が高い点があります。特に、乳がんや肺がん、前立腺がん、胃がん、頭頸部がんなど、様々ながんの治療に用いられています。ドセタキセルは、その効果に加えて、副作用としては主に血液の形態に影響を与えることが知られています。具体的には、白血球数の減少（白血球減少症）が一般的な副作用として見られ、これが感染症に対する感受性を高める要因となるため、患者の管理において注意が必要です。 ドセタキセルは、単独で使用される場合もありますが、他の抗がん剤や治療法と併用されることが多いです。併用療法は、複数の作用点を持つことで効果を高める狙いがあります。例えば、乳がん治療においては、アナストロゾールやトラスツズマブなどの薬剤と組み合わせて使用されることがあります。 ドセタキセルの投与方法は、一般的に静脈内注射（IV投与）が行われます。投与量は患者の体表面積や使用される療法の計画によって異なります。治療サイクルは通常、3週間ごとに設定されており、副作用の程度に応じて投与スケジュールが調整されることがあります。 ドセタキセルに関連する技術としては、がん治療における個別化医療が挙げられます。患者一人一人の遺伝的背景や腫瘍の特性に基づいて治療法を選択することが、ますます重視されています。また、近年の研究により、ドセタキセルが特定のバイオマーカーを持つ患者において、より高い治療効果を示す可能性が示唆されています。このような知見は、今後の治療戦略の構築に役立つと思われます。 さらに、新しい投与方式や製剤の開発が進められており、これにより副作用の軽減や効果の向上が期待されています。例えば、ドセタキセルをナノ粒子技術を用いて運搬することで、腫瘍組織に選択的に作用させる方法が研究されています。これにより、従来の投与法に比べて副作用を軽減し、治療効果を高める可能性が示唆されています。 ドセタキセルは、がん治療において非常に重要な役割を果たす薬剤ですが、その効果は個々の患者や病状によって異なるため、臨床では綿密なモニタリングと適切な管理が求められます。医師や看護師は、患者の状態に応じて用量や投与スケジュールを調整し、副作用の管理にも努めることが重要です。 つまり、ドセタキセル注射液は、抗がん治療において非常に重要な薬剤であり、その特徴や作用機序、投与方法、併用療法、関連技術に関する研究は、新たな治療戦略を生み出す上での重要な基盤となっています。今後のがん治療においても、ドセタキセルやその関連技術の進展は期待されており、患者の生活の質を向上させるための努力が続けられています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
